Abstract Details
|
Kathrin LaFaver, MD, FÂ鶹´«Ã½Ó³»
PRESENTER |
Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| No disclosure on file | |
| Alexandra E. Jacob, MS (University of Alabama Birmingham) | No disclosure on file |
| No disclosure on file |